HUP0103543A2 - Nyálkahártyán megtapadó hatóanyag bejuttató rendszerek és ezek alkalmazása állatok kezelésére - Google Patents

Nyálkahártyán megtapadó hatóanyag bejuttató rendszerek és ezek alkalmazása állatok kezelésére

Info

Publication number
HUP0103543A2
HUP0103543A2 HU0103543A HUP0103543A HUP0103543A2 HU P0103543 A2 HUP0103543 A2 HU P0103543A2 HU 0103543 A HU0103543 A HU 0103543A HU P0103543 A HUP0103543 A HU P0103543A HU P0103543 A2 HUP0103543 A2 HU P0103543A2
Authority
HU
Hungary
Prior art keywords
delivery systems
drug delivery
polymer
animal applications
systems
Prior art date
Application number
HU0103543A
Other languages
English (en)
Inventor
Luce R. M. Benes
Sophie G. Burgaud
Yen-Lane Chen
Francoise L. R. Horriere
Charles J. Matson
Daniel T. Ruth
Isabelle M. L. Seyler
Original Assignee
3M Innovative Properties Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Company filed Critical 3M Innovative Properties Company
Publication of HUP0103543A2 publication Critical patent/HUP0103543A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Abstract

A találmány nyálkahártyához tapadó rendszerekre és ezek alkalmazásáravonatkozik. Közelebbről a találmány helyi vagy szisztémás hatóanyag-bejuttatásra alkalmas, nyálkahártyán megtapadó hatóanyag bejuttatórendszerekre vonatkozik. Ezek a rendszerek különösen jól alkalmazhatókállatoknál. A hatóanyagot nyálkán keresztüli bejuttató rendszer akövetkezőket tartalmazza: - polimer gyanta; - lineáris elasztomerpolimer; - térhálósított elasztomer polimer, amely 30% és 80% közöttimértékben térhálósított; és - farmakológiai anyag, amelyben a lineáriselasztomer polimer térhálósított elasztomer polimerre vonatkoztatottaránya körülbelül 1 : 2 és 5 : 1 közötti. Ó
HU0103543A 1998-10-02 1999-10-01 Nyálkahártyán megtapadó hatóanyag bejuttató rendszerek és ezek alkalmazása állatok kezelésére HUP0103543A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10295698P 1998-10-02 1998-10-02
PCT/US1999/022967 WO2000019987A1 (en) 1998-10-02 1999-10-01 Mucosal originated drug delivery systems and animal applications

Publications (1)

Publication Number Publication Date
HUP0103543A2 true HUP0103543A2 (hu) 2002-01-28

Family

ID=22292601

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103543A HUP0103543A2 (hu) 1998-10-02 1999-10-01 Nyálkahártyán megtapadó hatóanyag bejuttató rendszerek és ezek alkalmazása állatok kezelésére

Country Status (19)

Country Link
EP (1) EP1117390B1 (hu)
JP (1) JP2002526403A (hu)
KR (1) KR20010075528A (hu)
CN (1) CN1321086A (hu)
AT (1) ATE273698T1 (hu)
AU (1) AU768040B2 (hu)
BR (1) BR9915020A (hu)
CA (1) CA2345808A1 (hu)
CZ (1) CZ20011188A3 (hu)
DE (1) DE69919554T2 (hu)
ES (1) ES2228125T3 (hu)
HU (1) HUP0103543A2 (hu)
IL (1) IL142168A0 (hu)
MX (1) MXPA01003310A (hu)
NO (1) NO20011656D0 (hu)
NZ (1) NZ510771A (hu)
PL (1) PL347061A1 (hu)
PT (1) PT1117390E (hu)
WO (1) WO2000019987A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
EP1844201B1 (en) 2005-02-04 2016-08-24 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
JP2006335640A (ja) * 2005-05-06 2006-12-14 Daicho Kikaku:Kk 動物用薬剤
WO2007013590A1 (ja) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム
WO2007103511A1 (en) * 2006-03-07 2007-09-13 Oramelts International, Inc. Multi-layer medical patch with impermeable center
KR101329496B1 (ko) * 2006-07-21 2013-11-13 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 향상된 흡수를 갖는 경점막 전달 장치
DE202008017304U1 (de) 2008-02-29 2009-08-27 Acino Ag Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren
US20110021588A1 (en) * 2009-05-15 2011-01-27 Recro Pharma, Inc. Sublingual dexmeditomidine compositions and methods of use thereof
CA2767673A1 (en) * 2009-07-17 2011-01-20 The Board Of Regents Of Oklahoma State University Supralingual vaccines and applicators
EP2570217B1 (de) 2011-09-15 2014-11-05 Klingelnberg AG Semi-Completing Wälzschälverfahren und Vorrichtung mit entsprechendem Wälzschälwerkzeug zum Ausführen eines Semi-Completing Wälzschälverfahrens
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
KR101831290B1 (ko) 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
ES2847936T3 (es) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
CA2924190C (en) * 2013-10-07 2019-07-09 Teikoku Pharma Usa, Inc. Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
CA2924188C (en) * 2013-10-07 2018-12-18 Teikoku Pharma Usa, Inc. Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
GB1455251A (en) * 1972-08-25 1976-11-10 Evode Ltd Method of sealing gaps and compositions therefor heat
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
FR2712807B1 (fr) * 1993-11-24 1996-02-23 Vetoquinol Sa Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine

Also Published As

Publication number Publication date
PT1117390E (pt) 2005-01-31
ATE273698T1 (de) 2004-09-15
NZ510771A (en) 2003-08-29
KR20010075528A (ko) 2001-08-09
JP2002526403A (ja) 2002-08-20
ES2228125T3 (es) 2005-04-01
EP1117390B1 (en) 2004-08-18
CN1321086A (zh) 2001-11-07
WO2000019987A1 (en) 2000-04-13
NO20011656L (no) 2001-04-02
PL347061A1 (en) 2002-03-11
EP1117390A1 (en) 2001-07-25
CZ20011188A3 (cs) 2001-08-15
AU768040B2 (en) 2003-11-27
CA2345808A1 (en) 2000-04-13
MXPA01003310A (es) 2003-05-15
NO20011656D0 (no) 2001-04-02
BR9915020A (pt) 2001-08-14
DE69919554D1 (de) 2004-09-23
DE69919554T2 (de) 2005-09-01
AU1100100A (en) 2000-04-26
IL142168A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
HUP0103543A2 (hu) Nyálkahártyán megtapadó hatóanyag bejuttató rendszerek és ezek alkalmazása állatok kezelésére
BR9906758A (pt) Método e composição para transferir zinco para a membrana nasal
DK1021204T3 (da) Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
HUP9900800A2 (hu) Szerves vegyületeket tartalmazó készítmények
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
AU7207098A (en) Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
HUP0002935A2 (hu) Gyomorban visszatartott, szabályozott hatóanyag kibocsátású mikrogömböcskék javított gyógyszeradagolás elősegítésére
DE69524772D1 (de) Ophthalmologisches abgabesystem
DE60122312D1 (de) Membranverabreichungssystem für wirkstoffe
MXPA05011028A (es) Sistemas de suministro de pelicula de gel termo-reversible homogenea que contiene carragenano kappa-2.
ES2130423T3 (es) Sistema de administracion intravaginal.
DK0871748T3 (da) Indgivelse af biologisk aktive polypeptider
ES2186769T3 (es) Complejos estables que comprenden lipidos para la administracion de farmacos y procedimientos para su produccion.
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
FI970788A0 (fi) Kasveilla käytettäviksi tarkoitettuja suihkutettavissa olevia, kalvon muodostavia järjestelmiä vaikuttavien aineiden antamiseksi
BR9901782A (pt) Forma para dosagem de nefazodona.
SE9300581L (sv) Komposition för nasalbehandling
BR9912275A (pt) Formulação de bioimplante
RS20070379A (en) Pharmaceutical compositions of tizoxanide and nitazoxide
NO993066L (no) Ny behandling for leddinflammasjon
NZ511214A (en) Drug delivery device, especially for the delivery of androgens
BR9709316A (pt) Composição farmacêutica para administração tópica no tratamento da vaginite